Status:

UNKNOWN

Mathematical Modeling of the Acute Inflammatory Response Following Injury

Lead Sponsor:

National Institute of General Medical Sciences (NIGMS)

Conditions:

Trauma

Critical Illness

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this research study is to gather clinical and biologic information from severely injured patients to better understand and characterize the host response to injury and inflammation acro...

Eligibility Criteria

Inclusion

  • Trauma patient cohort inclusion criteria:
  • Present for treatment of their acute, blunt or penetrating injuries to the University of Pittsburgh Medical Center within 6 hours of injury
  • Age greater than or equal to 18 years
  • Intact cervical spinal cord
  • Are admitted to the Intensive Care Unit
  • Trauma patient cohort exclusion criteria:
  • Anticipated survival \< 24 hrs
  • Anticipated survival \< 28 days due to pre-existing condition
  • Traumatic Brain injury (GCS ≤8 after ICU admission) AND brain CT abnormality within 12 hr of injury
  • Inability to obtain consent from the subject or their legally authorized representative.
  • Pre-existing immunosuppression
  • Transplant recipient
  • Chronic high doses of steroids (\>20 mg prednisone equivalents/day)
  • Significant likelihood of high dose steroids (e.g. spinal cord injury)
  • Oncolytic drug(s) therapy within the past 14 days
  • Known HIV positive status and CD4 count \< 200 cells/mm3
  • Admission to the ICU primary for substance withdrawal.
  • Inability to obtain 1st blood sample within 24 hours of injury.
  • Healthy volunteer cohort inclusion:
  • Age greater than or equal to 18 years
  • Weight \> 110 pounds
  • no recent illness or infection in the last two weeks
  • no recent hospitalization or trauma in the last month
  • Healthy volunteer cohort exclusion:
  • wt \< 110 lbs
  • infection or illness in the last two weeks
  • Hospitalization or trauma in the last month

Exclusion

    Key Trial Info

    Start Date :

    February 1 2003

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 1 2022

    Estimated Enrollment :

    520 Patients enrolled

    Trial Details

    Trial ID

    NCT00250523

    Start Date

    February 1 2003

    End Date

    July 1 2022

    Last Update

    March 2 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States, 15213